A team of Austrian researchers believes they have a practical answer. In a study published in BMC Bioinformatics, Markus Steiner, Stephan Drothler, Jan P. Höpner, Roland Geisberger and Nadja Zaborsky, based at Paracelsus Medical University, the Salzburg Cancer Research Institute and Paris-Lodron University Salzburg, introduce Spatialgater, an open, web-based tool built in R Shiny that lets scientists select individual cells directly on a zoomable image of their tissue. Rather than forcing analysts to write custom scripts every time they want to isolate, say, a cluster of immune cells sitting at the edge of a tumor nest, Spatialgater allows them to draw polygon gates around cells of interest with a few clicks of a mouse — in situ, exactly where the cells actually live.

The problem the tool addresses is rooted in how spatial omics data are currently processed. The dominant data structure in the R ecosystem for this kind of work is the SpatialExperiment class, a container that stores molecular expression measurements alongside the spatial coordinates of each cell. Standard analysis workflows built on this framework typically proceed by clustering cells according to their expression of biomolecules — proteins, transcripts or other markers — and then subsetting or annotating cells based on those molecular groupings. What these workflows largely ignore is geography. A tumor cell and its lookalike elsewhere on the slide may share nearly identical expression profiles, yet occupy radically different microenvironments, one nestled against a blood vessel, the other buried in dense stroma. Clustering alone cannot tell them apart by location.

Computational biologists have developed patch-detection and neighborhood-analysis methods that identify recurring spatial patterns, such as regions where particular cell types consistently co-occur. These approaches are powerful for systematic surveys of tissue architecture, but they are fundamentally automated and population-level. None of them gives a researcher the simple, immediate ability to say: show me these cells, right here, and let me select exactly the ones I mean. That gap matters in practice. Pathologists and immunologists often spot something visually striking — an unusual accumulation of T cells at an invasive margin, a suspicious ring of macrophages around a necrotic core — and want to interrogate those specific cells without writing bespoke code or approximating their region of interest with crude coordinate filters.

Spatialgater fills that gap with a deliberately simple interface. The tool renders cells as dots overlaid on a zoomable image of the tissue, so users can navigate the sample much as they would navigate a digital slide under a microscope. Drawing a polygon directly on the image selects every cell whose coordinates fall inside the drawn boundary. The selection is fully interactive: researchers can zoom in to single-cell resolution, refine a gate, add additional polygons and inspect the molecular profiles of the cells they have captured. Because the tool operates on SpatialExperiment objects, it slots naturally into existing R-based spatial omics pipelines rather than requiring researchers to export their data into an unfamiliar format.

Two features elevate the tool beyond a simple lasso. The first is an integrated k-nearest-neighbor function that can automatically extend a manually drawn gate across spatially similar microenvironments elsewhere in the tissue. If a researcher delineates a distinctive cellular neighborhood in one region, the algorithm can propagate that selection to comparable regions, dramatically reducing the manual labor of annotating large tissue sections while keeping the human judgment that defined the original gate. The second is traceability. Every polygon a user draws is recorded in a log file, creating an auditable record of exactly how each selection was made — a small but significant safeguard for reproducibility in a field where manual choices have traditionally gone undocumented.

Export and integration are equally considered. Selected cell identifiers can be written out as a standard CSV file for use in any downstream software, or saved directly back into the original SpatialExperiment object as a new logical column, meaning manual selections become first-class citizens in subsequent statistical analyses. This design choice reflects the authors’ core motivation: boosting interactivity while reducing the programming burden of image analysis. A researcher no longer needs to be a fluent R programmer to translate a visual observation into a computable cell set; the web interface handles the translation.

To demonstrate the tool in action, the team applied Spatialgater to a publicly available imaging mass cytometry dataset of breast cancer tissue, using it to characterize and compare T cells according to their spatial location within the tumor microenvironment. The demonstration speaks directly to one of the hottest questions in cancer immunology: how the precise positioning of immune cells — whether T cells are excluded from tumor nests, patrolling the invasive margin or dispersed through stroma — shapes antitumor immunity and predicts response to immunotherapy. A tool that makes spatially targeted cell selection fast and intuitive could accelerate exactly this kind of location-dependent immune analysis. The team also validated the package’s gating functionality using test data derived from a wild-type mouse, with the animal work approved by the Austrian Federal Ministry of Education, Science, and Research under approval number BMBWF 2023-0.644.528.

The significance of the work may lie less in any single algorithm than in what it signals about the maturing of spatial omics. The field’s first generation of tools focused on generating and processing data; the next generation is about making those data genuinely explorable by working biologists. By lowering the barrier between seeing something interesting in a tissue image and acting on it computationally, Spatialgater embodies a broader shift toward interactive, human-in-the-loop bioinformatics. The software is open access, published under a Creative Commons Attribution license, and funded by the Austrian Science Fund, WISS 2025 through the Cancer Cluster Salzburg, and the Province of Salzburg. For laboratories drowning in multiplexed images and struggling to connect visual insight with computational rigor, a free browser-based gate-drawing tool may prove to be one of those deceptively simple additions that changes daily practice.

Subject of Research: An interactive R Shiny web tool for spatially selecting and gating individual cells in spatial omics datasets.

Article Title: Spatialgater: an R Shiny webtool for in situ gating of cells in spatial omics experiments

Article References: Steiner, M., Drothler, S., Höpner, J. P., Geisberger, R., & Zaborsky, N. (2026). Spatialgater: an R Shiny webtool for in situ gating of cells in spatial omics experiments. BMC Bioinformatics. https://doi.org/10.1186/s12859-026-06620-y

Image Credits: AI Generated

DOI: 10.1186/s12859-026-06620-y

Keywords: Spatialgater, R Shiny, spatial omics, single cell gating, imaging mass cytometry, SpatialExperiment, multiplexed imaging, breast cancer, T cells, tumor microenvironment, bioinformatics software, Shiny

Traditionally, biologists have been constrained by analytical techniques that sacrifice spatial information, reducing tissues to a mixture of cells where location is lost. This limitation has hindered our comprehension of how cellular neighborhoods influence physiological and pathological states. The emergence of spatial transcriptomics and proteomics now permits high-resolution mapping of RNA and protein molecules inside intact tissues, lending an unprecedented spatial dimension to molecular profiling. Spatial transcriptomics reveals the location-specific gene expression patterns, whereas spatial proteomics identifies the distribution and interplay of functional proteins, thereby elucidating the molecular choreography underlying cellular behavior.

IRB Barcelona’s new platform uniquely integrates multiple core technologies encompassing spatial genomics, proteomics, histopathology, advanced microscopy, and bioinformatics into a seamless workflow designed to generate comprehensive spatially resolved molecular maps. This integrated approach not only enables rigorous sample processing and data acquisition but also incorporates sophisticated computational tools to interpret multilayered datasets. By combining these modalities, researchers can create detailed molecular atlases that reveal how distinct cell types and molecular states coalesce to maintain tissue homeostasis or drive disease progression.

The launch of this platform reflects IRB Barcelona’s longstanding commitment to pioneering technologies that push the boundaries of molecular biology. Over the last two decades, the institute has been a trailblazer in genomic microarrays and single-cell gene expression profiling from minimal samples, establishing itself as a reference center of excellence. Their prior innovations in proteomics, including advanced top-down analysis techniques, and the adoption of light-sheet microscopy for three-dimensional tissue imaging, have laid the foundation for this next leap forward into spatial biology.

This powerful platform facilitates detailed investigation of a wide array of diseases characterized by complex tissue architecture, including cancer, neurodegenerative disorders, cardiovascular ailments, and immune dysfunction. For instance, in oncology, spatial omics can elucidate the cellular heterogeneity within tumors, map the spatial distribution of resistant cell subpopulations, and unravel cellular interactions that influence tumor microenvironment and therapy response. Such spatially-informed molecular data are critical for understanding why certain therapies fail and for identifying novel, spatially targeted therapeutic interventions.

The uniqueness of IRB Barcelona’s initiative lies not only in its technological sophistication but also in its multidisciplinary and collaborative framework. By coordinating expertise from multiple core facilities, the platform delivers an end-to-end pipeline that spans from sample preparation to deep computational analysis. This holistic integration ensures scientific robustness, reproducibility, and the generation of high-resolution spatial datasets that can be cross-compared across studies and over time, accelerating discovery and translational applications.

Moreover, this platform serves as a national hub and a collaborative nexus, opening its infrastructure to the wider scientific community, including academic institutions, hospitals, and industry collaborators. Such open access fosters synergy, drives innovation, and broadens the impact of spatial omics technologies across Spain and internationally. It is envisaged that this initiative will significantly propel precision medicine, enabling patient-specific molecular diagnostics and the development of personalized therapeutic strategies grounded in spatial cellular biology.

A critical aspect of this platform is its integration of advanced computational methods. Spatial omics generates complex, multilayered data that requires novel bioinformatics algorithms to align and co-analyze transcriptomic, proteomic, and phenotypic information within spatial coordinates. IRB Barcelona’s bioinformatics teams are developing and implementing these sophisticated pipelines to construct multidimensional molecular landscapes of tissues. Such atlases not only enhance our understanding of tissue organization and function but also provide invaluable resources for hypothesis generation and mechanistic studies.

The platform is also a testament to successful collaborative funding efforts, having been supported by Spanish and Catalan governmental bodies, Next Generation funds, and prominent foundations such as the Spanish Association Against Cancer, La Caixa Foundation, and the BBVA Foundation. This financial backing underscores the importance and potential impact of spatial omics on public health and biomedical research.

Looking ahead, the integration of spatial omics with other emerging technologies such as single-cell multi-omics and advanced imaging modalities promises to unlock even deeper insights into cellular ecosystems. The ability to spatially resolve multiple biomolecular layers simultaneously will provide a holistic view of biological systems, bridging the gap between molecular detail and tissue physiology. This comprehensive understanding is essential to confront the complexities of human diseases and to develop innovative treatment paradigms.

By enabling researchers to ‘see biology in place’, IRB Barcelona’s Spatial Omics Platform is not merely an incremental technological upgrade but represents a paradigm shift in life sciences. It turns the metaphor of the body as a city into a tangible reality, where cells, genes, and proteins are mapped with neighborhood precision. This spatial perspective is critical for decoding cellular behavior within the rich tapestry of tissue architecture and microenvironmental influences, ultimately advancing both basic biology and precision medicine.

In sum, this pioneering facility positions IRB Barcelona at the forefront of spatial biology, empowering scientists to unlock the spatial dimension of molecular biology that has remained elusive until now. The resulting knowledge is expected to transform our approach to diagnosing, treating, and preventing diseases with unprecedented accuracy and specificity, heralding a new era in biomedical research.

Subject of Research: Spatial Omics, Spatial Transcriptomics, Spatial Proteomics, Integrated Molecular Profiling

Article Title: IRB Barcelona Launches Spain’s First Integrated Spatial Omics Platform Revolutionizing Molecular Mapping in Tissues

News Publication Date: 9 February 2026

Image Credits: IRB Barcelona

Keywords: Genomics, Proteomics, Microscopy, Cancer, Bioinformatics, Health and Medicine